Evidence map›Paper›PMID 41339459›Full record

ArticleScientific reports2025

Fusion-ADiNet: a multi-level framework for enhanced diabetes and Alzheimer's disease detection using chimp-whale fusion estimation.

Roobini Ms, Mong-Fong Horng, Siva Shankar S, Nagarajan G

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Roobini MsNational Kaohsiung University of Science and Technology, No. 415, Jiangong Road, Kaohsiung, Taiwan. roobinims@gmail.com.
Mong-Fong HorngDepartment of Electronics Engineering, National Kaohsiung University of Science and Technology, No. 415, Jiangong Road, Kaohsiung, Taiwan.
Siva Shankar SDepartment of CSE, KG Reddy College of Engineering and Technology, Hyderabad, Telangana, India.
Nagarajan GDepartment of Computer Science and Engineering, Sathyabama Institute of Science and Technology, Chennai, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rising cases of diabetes and AD are the two biggest health-related issues world-wide; this greatly hampers the quality of life among the afflicted persons. Early identification of diabetes most especially correlated with neurodegenerative conditions such as Alzheimer's guarantees early intervention and hence proper management. However, the existing approaches for disease detection have been suffering from a series of limitations in poor diagnostic accuracy, high computational complexity, and the lack of an effective model that could properly handle the intricate correlations between diabetes and AD. Most of the existing methods for diabetes and AD detection rely on traditional machine-learning algorithms or heuristic optimization approaches, which are not capable of handling high dimensionality and complex clinical data. The models also find it extremely difficult to represent the subtle relationship between the two diseases, leading to unsatisfying performance in practical applications. It is therefore imminent to develop much more advanced methodologies with integration that could improve accuracy in prediction, enabling better decision-making in clinics. To overcome the limitations of existing methods, in this paper, we propose a new approach called Fusion-Alzheimer's Diabetes Network (Fusion-ADiNet) by introducing a multi-level fusion framework for disease detection. The main novelty in this method lies in the newly designed Chimp-Whale Fusion Estimator (CWFE) optimization algorithm. Furthermore, the Fusion-ADiNet framework is quite flexible, so extending it to other diseases or datasets in the future will be very easy. This work contributes much to the field of healthcare analytics and opens new perspectives toward more effective diagnostic tools for timely detection of diabetes and Alzheimer's disease.

Indexed as

Alzheimer DiseaseDiabetes MellitusAlgorithmsHumansMachine LearningAlzheimer diseases (AD)ClassificationDeep learningDiabetes mellitus (DM)Disease diagnosisOptimization

Identifiers

PMID41339459
PMCPMC12775445

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.